Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1997-12-30
2000-01-25
Draper, Garbette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
530350, 424 852, C07K 1454
Patent
active
060180293
ABSTRACT:
Canine IL-1 receptor antagonist protein, DNAs, and expression vectors carrying DNA sequence encoding canine IL-1 receptor antagonist are disclosed.
REFERENCES:
patent: Re35450 (1997-02-01), Dower et al.
patent: 4894333 (1990-01-01), Cerretti et al.
patent: 4902708 (1990-02-01), Kim
patent: 4968607 (1990-11-01), Dower et al.
patent: 4975464 (1990-12-01), Imaki et al.
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5081228 (1992-01-01), Dower et al.
patent: 5180812 (1993-01-01), Dower et al.
patent: 5196402 (1993-03-01), Braganza et al.
patent: 5220018 (1993-06-01), Bock et al.
patent: 5286739 (1994-02-01), Kilbourn et al.
patent: 5286847 (1994-02-01), Gehrke et al.
patent: 5296592 (1994-03-01), Dower et al.
patent: 5319071 (1994-06-01), Dower et al.
patent: 5334380 (1994-08-01), Kilbourn et al.
patent: 5350683 (1994-09-01), Sims et al.
patent: 5455330 (1995-10-01), Haskill et al.
patent: 5464937 (1995-11-01), Sims et al.
patent: 5488032 (1996-01-01), Dower et al.
patent: 5492888 (1996-02-01), Dower et al.
patent: 5508262 (1996-04-01), Norman
patent: 5552536 (1996-09-01), Nicholson et al.
patent: 5563046 (1996-10-01), Mascarenhas et al.
Pickvance, et al., "Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading," J. of Ortho. Res., 1993; 11(3):313-3223.
Shuster, et al., "Administration of recombinant human interleukin 1 receptor antagonist during endotoxin-induced mastitis in cows," American Journal of Veterinary Research, 1995; 56:313-320.
Waage and Espevik, "Interleukin 1 Potentiates the Lethal Effect of Tumor Necrosis Factor .alpha./Cachectin in Mice," J. Exp. Med., 1988; 167:1987-1992.
Wakabayashi, et al., "A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits," The FASEB Journal, 1991; 5:338-343.
Zahedi, et al., "The mouse interleukin 1 receptor antagonist protein: Gene structure and regulation in vitro," Cytokine 1994; 6:1-9.
Aiura, et al., "Interleukin-1 (IL-1) Receptor Antagonist Prevents Staphylococcus epidermidis-Induced Hypotension and Reduces Circulating Levels of Tumor Necrosis Factor and IL-1.beta. in Rabbits," Infection and Immunity, Aug. 1993, pp. 3342-3350.
Benton and Davis, "Screening gt Recombinant Clones by Hybridization to Single Plaques in situ," Science, Apr. 1977, pp. 180-182.
Bilgen, et al., "Attempts to Reduce Post-Transplant Pancreatitis in Rats and Dogs with the Somatostatin Analogue SMS 201-995," Trans. Proc., 1989; 21(1):2829-2830.
Caron et al., "Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Supression of collagenase-1 expression," Arthritis and Rheumatism, 1996; 39:1535-1544.
Carter, et al. "Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist," Nature, 1990; 344:633-638.
Cominelli, et al., "Rabbit Interleukin-1 Receptor Antagonist,". J. of Biol. Chem., 1994; 269:6962-6971.
Dinarello, et al., Interleukin-1 and Interleukin-1 Receptor Antagonist., Nutrition, 1995; 11:492-494.
Dinarello, et al., "Interleukin-1 and Interleukin-1 Antagonism," Blood, 1991; 77:1627-1643.
Eisenberg, et al., "Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist," Nature, 1990; 343:341-346.
Eisenberg, et al., "Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: Evolution of a cytokine control mechanism," Immunology, 1991; 88:5232-5236.
Evans, et al., "Progress toward the Treatment of Arthritis by Gene Therapy," Annals of Medicine, 1995; 27:543-546.
Fernandes, et al., "Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model.Suppresion of metalloprotease and interleukin-1 activity," Arthritis ans Rheumatism, 1997; 40:284-294.
Fischer, et al., Comparision between effects of interleukin-1 administration and sublethal endotoxemia in primates, the American Physiological Society, 1991:R442-R452.
Fischer, et al., "Interleukin-1 Receptor Blockade Improves Survival and Hemodynamic Performance in Escherichia coli Septic Shock, but Fails to Alter Host Responses to Sublethal Endotoxemia," J. Clin. Invest., 1992 89:1551-1557.
Goto, et al., "Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure," Immunology 1992; 77: 235-244.
Charles A. Dinarello, M.D., Supplement to Nutrition, 1995, vol. 11, No. 5: 492-497.
C. H. Evans and P. D. Robbins, Annals of Medicine, 1995, 27:543-546.
J. Lewthwait, Journal of Rheumatology, Mar. 21(3):467-72.
Fabio Cominelli, The Journal of Biological Chemistry, Mar. 4, 1994, vol. 269, pp. 6962-6971.
GL Hung, Gene Therapy, Jan., 1994, 1(1):64-9.
Kamyar A. Zahedi, Cytokine, Jan., 1994, vol. 6, No. 1, pp. 1-9.
Koichhi Aiura, Infection and Immunity, Aug., 1993, vol. 61, No. 8, pp. 3342-3350.
J. Martel-Pelletier, Biochimica et Biophsica Acta., Feb. 17, 1993, 1175(3):302-305.
James A. Lederer, Journal of Leukocyte Biology, Jun., 1992, vol. 51, pp. 586-590.
Eva Fischer, Journal of Clinical Investigation, May, 1992, vol. 89, pp. 1551-1557.
F. Goto, Immunology, 1992, vol. 77, pp. 235-244.
Andrew Lennard, Cytokine, Mar., 1992, vol. 4, No. 2, pp. 83-89.
Hitoshi Matsuchime, Blood, Aug. 1, 1991, vol. 78, No. 3, pp. 616-623.
Charles A. Dinarello, Blood, Apr. 15, 1991, vol. 77, No. 8, pp. 1627-1652.
Go Wakabayashi, The FASEB Journal, Mar., 1991, vol. 5, pp. 338-343.
S. P. Eisenberg, Proc. Natl. Acad. Sci. USA, Jun., 1991, Immunology, vol. 88, pp. 5232-5236.
Kjell Ohlsson, Nature, Dec. 6, 1990, vol. 348, pp. 550-552.
D. B. Carter, Nature, Apr. 12, 1990, vol. 344, pp. 633-638.
Stephen B. Eisenberg, Nature, Jan. 25, 1990, vol. 343, pp. 341-346.
E. J. Sillenaar Bilgen, Transplantation Proceedings, Feb., 1989, vol. 21, No. 1, pp. 2829-2830.
C. Natanson, Journal of clinical Investigation, Jan., 1989, 83(1):243-251.
Seijiro Okusawa, Journal of Clinical Investigation, Apr., 1988, vol. 81, pp. 1162-1172.
Anders Waage, Journal of Experimental Medicine, Jun., 1988, vol. 167, pp. 1987-1992.
H. Okayama, Molecular & Cellular Biology, Feb., 1983, 3(2):280-289.
W. David Benton, Science, vol. 196, Apr. 8, 1977, pp. 180-182.
Granowitz, et al., "Pharmacokinetics, Safety and Immunomodulatory Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Healthy Humans," Cytokine, 1992 4(5):353-360.
Haskill, et al., "cDNA Cloning of an Intracellular Form of the Human Interleukin 1 Receptor Antagonist Associated with Epithelium," Proc. Natl. Acad. Sci. USA, 1991 88(9):3681-5.
Houssiau, "Cytokines in rheumatoid arthritis," Clinical Rheumatology, 1995 14 Suppl. 2:10-3.
Hung, et al., "Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium," Gene Therapy 1994; 1:64-69.
Lebedenko and Berlin, "PCR-Mediated Synthesis of a Gene Coding for the Interleukin 1 Receptor Antagonist," Bioorg. Khim., 19(5): 586-8 (1993).
Lederer and Czuprynski, "Characterization and identification of interleukin 1 receptors on bovine neutrophils," Journal of Leukocyte Biology 1992; 51:586-590.
Lennard, et al., "Cloning and Chromosome Mapping of the Human Interleukin-1 Receptor Antagonist Gene," Cytokine 1992; 4:83-89.
Lewthwaite, et al., "The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit," Journal of Rheumatology 1994; 21:467-472.
Martel-Pelletier, et al., "The synthesis of IL-1 receptor antagonist (IL-1ra) by synovial fibroblasts in markedly increased by the cytokines TNF-alpha and IL-1," Biochimica et Biophysica Acta. 1993; 1175(3)302-5.
Matsushime, et al., "Cloning and Expression of Murine Interleukin-1 Receptor Antagonist in Macrophages Stimulated by Colony-Stimulating Factor 1," Blood 1991; 78:616-623.
Natanson, et al., "Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock," Jour. of Clin. Invest. 1989; 83(1):243-251.
Ohlsson,
Fuentes Nelson Luis
Fuller Gerald Maxwell
Draper Garbette D.
Gray Bruce D.
Kaufman Rebecca J.
UAB Research Foundation
LandOfFree
DNA encoding canine interleukin-1 receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding canine interleukin-1 receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding canine interleukin-1 receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316649